Pages that link to "Q26777994"
Jump to navigation
Jump to search
The following pages link to Nephroprotection by Hypoglycemic Agents: Do We Have Supporting Data? (Q26777994):
Displaying 7 items.
- Effects of canagliflozin on cardiovascular risk factors in patients with type 2 diabetes mellitus. (Q33845734) (← links)
- SGLT2 Inhibitors: Glucotoxicity and Tumorigenesis Downstream the Renal Proximal Tubule? (Q38667712) (← links)
- Association of Increasing GFR with Change in Albuminuria in the General Population (Q40561359) (← links)
- Renoprotective Effects of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin: A Review in Type 2 Diabetes (Q42876331) (← links)
- Role of the sodium-hydrogen exchanger in mediating the renal effects of drugs commonly used in the treatment of type 2 diabetes. (Q48141985) (← links)
- Canagliflozin and Renal Events in Diabetes with Established Nephropathy Clinical Evaluation and Study of Diabetic Nephropathy with Atrasentan: what was learned about the treatment of diabetic kidney disease with canagliflozin and atrasentan? (Q64915448) (← links)
- Odds of Acute Kidney Injury in Patients Receiving Dipeptidyl Peptidase 4 Inhibitors: A National Cohort Study Within the Department of Veterans Affairs (Q92670582) (← links)